Development and Validation of an Implementation Penetration Assessment Criteria Tool (ImPACT-HPV) for HPV Vaccination in Nigeria

NIH RePORTER · CA · F31 · $37,941 · view on reporter.nih.gov ↗

Abstract

There exists a research-to-practice gap that hinders the penetration of human papillomavirus (HPV) vaccination among adolescent girls and young women in Nigeria. To close this gap requires reliable, validated, easy-to-use tools to identify and measure elements of penetration that drive high performance of HPV vaccination uptake in resource limited settings. Penetration, defined here as the integration of evidence (i.e. HPV vaccines) within the culture of recipient setting or community through policies and practices remains incompletely understood in low resource settings. Currently, existing measures for penetration suggest that there are three stages that determine the extent of integration within service settings: 1) passages (i.e. single event); 2) routines (repetitive reinforcement of interventions) and 3) niche saturation (or extent in which intervention is integrated). However, these measures often confound several dynamic processes inherent with integrating evidence-based interventions within resource limited settings. They also provide no insight on the multidimensional nature of penetration or whether it may be influenced by important determinants such as: 1) perceptions of passages; 2) enablers or resources for routines; and 3) nurturers or assets for niche saturation. In response to NCI’s Strategic Plan to advance cancer prevention research and increase HPV vaccination coverage. The overall goal of this F31 is to develop a reliable, valid, and pragmatic assessment tool to identify core features of penetration related to high uptake of HPV vaccines. We proposed to develop the Implementation Penetration Assessment Criteria Tool (ImPACT) with the guidance of the perceptions, enablers, and nurturers domain of the PEN-3 cultural model developed by Airhihenbuwa to address the determinants highlighted above. This study, which builds on the recently funded ACCESS study (R01 CA271033: PI: Iwelunmor: Actions for Collaborative Community Engages Strategies for HPV),

Key facts

NIH application ID
11300931
Project number
5F31CA294971-02
Recipient
WASHINGTON UNIVERSITY
Principal Investigator
Onyekachukwu Anikamadu
Activity code
F31
Funding institute
CA
Fiscal year
2026
Award amount
$37,941
Award type
5
Project period
2025-02-05T00:00:00 → 2027-02-04T00:00:00